PT-141
A peptide therapy that supports sexual wellness by working with the body's natural neurological pathways to enhance desire and intimacy for both men and women.
What is PT-141?
PT-141, also known as bremelanotide, is a synthetic peptide that acts as a melanocortin receptor agonist. Unlike medications that work by increasing blood flow, it is understood to act on pathways in the central nervous system that are involved in sexual desire and arousal.
A branded bremelanotide product is FDA-approved for premenopausal women with hypoactive sexual desire disorder, and in that form it is a self-administered subcutaneous injection taken as needed rather than daily. That branded product is not what Rx2BFIT dispenses. Use in men, and for any other purpose, sits outside the approved indication, and research on those uses is ongoing.
Peptides are not shortcuts or miracle solutions. They are specialized compounds that work with the body’s natural signaling systems to support specific biological functions.
Rx2BFIT does not dispense a branded or FDA-approved PT-141 product, and it does not use a compounding pharmacy. The PT-141 used at the practice comes from a U.S.-based supplier whose batches are tested by an independent laboratory for identity and purity, with a certificate of analysis on file, and it is reconstituted in the office under Dr. Patel's supervision. It is not an FDA-approved medication. Dr. Patel reviews that, along with the known risks, the potential side effects, and the limits of the evidence, before anyone starts.
A consultation is required to determine the most appropriate treatment plan.
May help support:
- Sexual wellness
- Libido
- Confidence
- Intimacy
A personalized, physician-guided approach
Sexual wellness
Bremelanotide was developed specifically for sexual wellness. It is one of the few therapies in this area that is understood to act on desire itself rather than on blood flow.
Libido
By activating melanocortin receptors in the brain, PT-141 is thought to influence the neurological pathways associated with sexual desire. Individual response varies, and research is ongoing.
Taken as needed
Bremelanotide is a subcutaneous injection taken before anticipated sexual activity, not a daily medication. It is commonly used on an as-needed basis rather than as a continuous therapy.
Medical oversight
Peptide therapy should always be approached responsibly and under qualified medical supervision.
Am I a candidate for PT-141?
Every patient is different, which is why Rx2BFIT doesn't believe in one-size-fits-all treatment plans.
During your consultation, Dr. Bhavesh Patel will review your health history, discuss your goals, and recommend a personalized program based on your needs.
This program may be right for you if you:
Feel like your energy isn't what it used to be
Are interested in preventative wellness
Want to maintain an active lifestyle
Are looking for physician-guided longevity support
Frequently asked questions
Is everything medically supervised?
Yes. All programs are overseen by Dr. Bhavesh Patel, with ongoing monitoring to ensure safety, effectiveness, and proper adjustments over time.
What is PT-141?
PT-141 is the common name for bremelanotide, a synthetic peptide that activates melanocortin receptors. It is understood to act on central nervous system pathways involved in sexual desire rather than on blood flow, which distinguishes it from medications such as sildenafil.
Is PT-141 FDA-approved?
A branded bremelanotide product is FDA-approved for premenopausal women with acquired, generalized hypoactive sexual desire disorder. The PT-141 used at Rx2BFIT is not that product and is not FDA-approved, and use in men, in postmenopausal women, or for any other purpose sits outside the approved indication.
Does PT-141 work for men?
PT-141 has been studied in men, including early trials for erectile dysfunction, but it is not FDA-approved for use in men. Evidence is limited and research is ongoing.
How is PT-141 taken?
Bremelanotide is a self-administered subcutaneous injection taken as needed before anticipated sexual activity, not a daily medication. Whether and how it fits into any individual's care is a decision for a prescribing clinician.
What are the known side effects of PT-141?
The most commonly reported side effects in clinical trials of bremelanotide were nausea, flushing, injection site reactions, and headache. It can cause a temporary increase in blood pressure, so it is generally not recommended for people with uncontrolled high blood pressure or known cardiovascular disease. Some users have reported darkening of the skin, particularly with frequent use.
Where to next?
From the blog
How Does PT-141 (Bremelanotide) Work?
PT-141 (bremelanotide) acts on melanocortin receptors in the brain, not on blood flow. See how it works, what the RECONNECT trials found, and its FDA status.
Read the articleFrom the blog
PT-141 Side Effects and Safety: What to Know Before Starting
PT-141 (bremelanotide) side effects with label frequencies: nausea, flushing, blood pressure rise, skin darkening, dosing limits, and non-approved product risks.
Read the articleFrom the blog
Does GHK-Cu Help With Hair Growth?
GHK-Cu has lab and animal data for hair follicles but no human trial of its own. See the studies, the FDA status, and how it compares with proven options.
Read the article
Your free assessment is the first step.
Ready to look, feel, and perform better?
Last updated .